ResearcherUniversity of FloridaActive in the last 2 years
Kenneth Luberice
Matched on ORCID iD 0000-0002-8065-8405; OpenAlex author ID A5013741679. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- Association of County-level Social Determinants and Pancreatic Cancer Incidence in the United States. Co-author DOI 10.21873/anticanres.17622↗
- Has survival improved following resection for pancreatic adenocarcinoma? Co-author DOI 10.1016/j.amjsurg.2017.05.007↗
- Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. Co-author DOI 10.1097/ij9.0000000000000015↗
- Can pancreatic cancer behavior be predicted based on computed tomography measurements of fat and muscle mass? Co-author DOI 10.1097/ij9.0000000000000004↗
- Increasing body mass index portends abbreviated survival following pancreatoduodenectomy for pancreatic adenocarcinoma. First author DOI 10.1016/j.amjsurg.2014.12.037↗
- Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1177/000313481307900818↗
- Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splene… Co-author DOI 10.1007/s11605-011-1765-6↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alexander S. Rosemurgy · 6 shared papers, 2012–2017 · strength 0.38
- Paper Has survival improved following resection for pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2017.05.007↗
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Can pancreatic cancer behavior be predicted based on computed tomography measurements of fat and muscle mass? DOI 10.1097/ij9.0000000000000004↗
- Sharona B Ross · 5 shared papers, 2012–2017 · strength 0.32
- Paper Has survival improved following resection for pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2017.05.007↗
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Can pancreatic cancer behavior be predicted based on computed tomography measurements of fat and muscle mass? DOI 10.1097/ij9.0000000000000004↗
- Alexander Scott Parker · 1 shared paper, 2025 · strength 0.26
- Erin Michele Mobley · 1 shared paper, 2025 · strength 0.26
- Ziad T. Awad · 1 shared paper, 2025 · strength 0.26
- Paul G. Toomey · 3 shared papers, 2012–2017 · strength 0.16
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1177/000313481307900818↗
- Paper Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who … DOI 10.1007/s11605-011-1765-6↗
- Whalen Clark · 1 shared paper, 2016 · strength 0.07
- Abhishek Mathur · 1 shared paper, 2015 · strength 0.06
- Jonathan Matthew Hernandez · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.